Keyphrases
90-day Readmission
15%
Addiction Care
16%
Antibiotics
40%
Bacteremia
18%
Barriers to Care
13%
Biofilm
62%
Biofilm Bacteria
12%
Biofilm Dispersion
18%
Biofilm Formation
62%
Biofilm Growth
16%
Care Coordination
20%
Cascade of Care
27%
Commensal
12%
Cost-effectiveness
18%
COVID-19
14%
Epithelial Cells
15%
Genetic Exchange
28%
Harm Reduction
27%
Human Milk Proteins
27%
In Care
20%
Infective Endocarditis
20%
Influenza Virus
19%
Injectable Drugs
18%
Injection Drug Use
84%
Injection-related Infections
58%
Invasive Disease
16%
Lipid Transfer Protein
29%
Medications for Opioid Use Disorder
20%
Membrane Depolarization
12%
Membrane Polarity
12%
Nasopharyngeal
17%
Nasopharyngeal Carriage
15%
Nasopharynx
24%
Opioid Use Disorder
38%
Opioid Use Disorder Treatment
20%
Oral Antibiotics
26%
People Who Inject Drugs
77%
People Who Use Drugs
12%
Planktonic Bacteria
12%
Pneumococcal Disease
13%
Pneumococcus
55%
Pre-exposure Prophylaxis (PrEP)
12%
Referral Program
13%
S. Pneumoniae
21%
Screening Rate
15%
Sexually Transmitted Infections
15%
Staphylococcus Aureus
23%
Streptococcus Pneumoniae
84%
Streptococcus Pyogenes (S. pyogenes)
20%
Treatment Referral
13%
Medicine and Dentistry
Addictive Behavior
25%
Antibiotic Therapy
19%
Antibiotics
20%
Antimicrobial Therapy
8%
Bloodstream Infection
12%
Care Coordination
16%
Combination Therapy
18%
Cost-Effectiveness Analysis
18%
COVID-19
18%
Diseases
10%
Drug Use
65%
Endocarditis
7%
Epidural Abscess
6%
Fungemia
5%
Harm Reduction
22%
Health Care
5%
Health Care Cost
14%
Hepatitis C
10%
Hepatitis C Virus
9%
Hepatitis Virus
7%
Holistic Care
9%
Human Immunodeficiency Virus
15%
Human Milk
9%
Infection
78%
Infectious Disease
6%
Infective Endocarditis
19%
Medical Record
5%
Metabolome
9%
Myositis
5%
Oral
26%
Osteomyelitis
5%
Outpatient
31%
Outpatient Care
5%
Patient Experience
9%
Patient Referral
24%
Pneumococcal Pneumonia
9%
Primary Health Care
9%
Protein Lipid Interaction
9%
Respiratory Tract Infection
9%
Septic Arthritis
6%
Sexually Transmitted Disease
12%
Staphylococcal Bacteremia
9%
Staphylococcus Aureus
5%
Streptococcus Pneumonia
9%
Substance Use Disorder
11%
Telemedicine
11%
Thrombophlebitis
5%
Virus
6%
Immunology and Microbiology
Antibiotic Resistance
7%
Bactericidal Activity
5%
Biofilm
84%
Budding Yeast
9%
Burkholderia
9%
Calcium Transport
5%
COVID-19
9%
Dispersion
18%
Enzyme Activity
6%
Fomite
9%
Genetic Recombination
9%
Genetic Transformation
9%
Hepatitis C Virus
9%
Human Immunodeficiency Virus
9%
In Vitro
40%
Infection
53%
Infectious Agent
34%
Influenza Virus
10%
Influenzavirus A
12%
Ion Transport
8%
Lineages
9%
Liquid Chromatography
6%
Membrane Depolarization
7%
Membrane Potential
5%
Metabolome
9%
Nasopharynx
17%
Pneumococcus
13%
Protein A
9%
Protein Lipid Interaction
29%
Respiratory Virus
9%
Sensitization
9%
Staphylococcus Aureus
25%
Streptococcus
7%
Streptococcus Group A
6%
Streptococcus Pneumonia
100%
Streptococcus pyogenes
20%
Superoxide
9%
Transcriptome
9%
Tumor Cell
9%
Viral Disease
12%
Whole Cell
6%
